nCounter Neuroscience Grant Program | EMEA

Open to researchers in Europe, Middle East and Africa. Helping your research with gene expression you can count on.

Kick off your next Neuroscience Research project with the opportunity to win 24 samples of the nCounter® Neuropathology, Neuroinflammation or Glial Panel. To apply, simply submit a 500-word abstract by Friday 3rd March, 2023.

The nCounter® platform provides a simple and cost-effective solution for multiplex analysis of up to 800 RNA, DNA, or protein targets. Accelerate your research with just 15 minutes total hands-on time without amplification, cDNA conversion, or library prep, and generate publication-ready figures in ~24 hours.

Select from curated, multiplexed nCounter Gene Expression Panels to build your own experiment. Take advantage of embedded CNS and immune cell typing signatures to quantify the relative abundance of 5 CNS cell types and 14 different immune cell types. 

Learn more about the Neuroscience Panels below:

nCounter® Neuropathology Panel

nCounter® Neuroinflammation Panel

nCounter® Profiling Glial Panel

nCounter® Metabolic Pathways Panel

Not sure which panel best fits your research? Explore our panel offerings.

One grant recipient will be awarded 24 samples of the panel of their choice, along with appropriate master kit or SPRINT cartridges, 1:1 Project Consultation, and Data Analysis Walkthrough. The Metabolic Pathways panel could be used alongside one of the neuro panels as a complementary option for neuro projects. In this case, the award would include 1x Neuroscience panel (of your choice) and 1x Metabolic pathways panel.

Terms & Conditions

Award Selection Criteria:

  • Project feasibility in a 3 month period
  • Panel already available and on-shelf (no custom design permitted)
  • Potential to publish the results on high impact factors (and number of articles) as determined by the judges

Grant submissions must be received by 11:59 PM GMT on Friday 3rd March, 2023.

Publication of Project Results:
Upon project completion, the grant winner agrees to participate in one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString and the winner: local seminar, webinar, case study, blog post, or poster presentation. Each winner agrees that NanoString shall have the right to use de-identified data from the winner’s project in application notes or marketing literature.

Eligibility and Requirements:
Applicants must be actively enrolled or employed at an institution or company in a capacity in which they perform life science research as a postdoctoral research fellow, research fellow, etc. Recipients must be age 18 or older. Members of the immediate families of NanoString employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this travel award grant program. The grant award allows for the recipients to run 24 samples worth of an nCounter neuroscience gene expression panel (choosing from the Neuropathology, Neuroinflammation, Glial Profiling, and Alzheimer’s Disease Panels) along with samples of Master Kits or Sprint Cartridges, whichever is applicable. Projects can be run at the recipient’s institution or on a local nCounter instrument. A basic data analysis service and report will also be provided.

By submitting an application, each applicant agrees that NanoString may use his or her name, abstract title, and abstract for marketing purposes. All applicants agree that NanoString may process the personal data he or she provides as part of the application, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at Award recipients may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString. No substitution or transfer of the awarded stipend is allowed, except as otherwise permitted by NanoString. Grant winners are responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, this grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. NanoString has not made any warranty, representation, or guarantee, express or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose. This program is void where prohibited or otherwise restricted by law. These terms and conditions and any action related to this grant award program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.

For Research Use Only. Not for use in diagnostic procedures.

Applications are now closed